We can't find the internet
Attempting to reconnect
18012.1 PFLS-LS
18012.1 PFLS-LS
Résumé
Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders
Textes supplémentaires
Abstract
This follow-up project aims at optimizing existing small molecule lead series previously designed as potent and selective inverse agonists of the ghrelin receptor. The ultimate goal is to obtain preclinical drug candidates for the development of an innovative parenteral therapy of obesity linked with type 2 diabetes or other metabolic syndromes.
Participants
Sergio Cantoreggi
Wirtschaftspartner
sergio.cantoreggi@helsinn.com
Helsinn SA Sergio Cantoreggi Scairolo 9 6912 Pazzallo (Lugano) TI CH
Olivier Michielin
Kontaktperson
olivier.michielin@unil.ch
Swiss Institute of Bioformatics (SI Olivier Michielin Bâtiment Genopode / Quartier Sorge 1015 Lausanne VD CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2015-08-02
- Date de fin
- 2016-01-02
- Coûts totaux approuvés
- CHF 71047.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%